Fate Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts that cover Fate Therapeutics stock have a consensus rating of "Buy" and an average price target of $3.92, which forecasts a 164.86% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $7.00.

Price Target: $3.92 (+164.86%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.00	$3.92	$4.00	$7.00
Change	+35.14%	+164.86%	+170.27%	+372.97%

* Price targets were last updated on Oct 31, 2025.

Analyst Ratings

The average analyst rating for Fate Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	0	1	1	1	1	1
Buy	1	2	2	2	2	2
Hold	6	4	4	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Hold → Strong Buy Upgrades $5	Hold → Strong Buy	Upgrades	$5	+237.84%	Oct 31, 2025
David Nierengarten Wedbush	Wedbush	Hold → Buy Upgrades $5 → $7	Hold → Buy	Upgrades	$5 → $7	+372.97%	Oct 27, 2025
Gil Blum Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Oct 27, 2025
Yanan Zhu Wells Fargo	Wells Fargo	Hold Maintains $4 → $2.5	Hold	Maintains	$4 → $2.5	+68.92%	Aug 13, 2025
Gil Blum Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Jun 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

5.36M

from 6.65M

-19.38%

from 6.65M

Revenue Next Year

3.88M

from 5.36M

-27.66%

from 5.36M

EPS This Year

-1.17

from -1.15

EPS Next Year

-1.08

from -1.17

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	55.85M	96.30M	63.53M	13.63M	6.65M	5.36M	3.88M
Revenue Growth	77.66%	72.44%	-34.03%	-78.55%	-51.24%	-19.38%	-27.66%
EPS	-2.24	-2.91	-1.64	-1.64	-1.15	-1.17	-1.08
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	15	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	10.5M	8.0M
Avg	5.4M	3.9M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	58.0%	48.9%
Avg	-19.4%	-27.7%
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.96	-0.85
Avg	-1.17	-1.08
Low	-1.34	-1.27

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.